Pathogenesis and treatment of systemic lupus erythematosus nephritis
A Davidson, C Aranow - Current opinion in rheumatology, 2006 - journals.lww.com
A Davidson, C Aranow
Current opinion in rheumatology, 2006•journals.lww.comAlthough there has been remarkable progress in our understanding of the immunology and
phenotype of lupus nephritis current therapies have insufficient efficacy. As new therapies
emerge, improved clinical design coupled with mechanistic studies will be needed to identify
agents that may be effective only in some patient subpopulations.
phenotype of lupus nephritis current therapies have insufficient efficacy. As new therapies
emerge, improved clinical design coupled with mechanistic studies will be needed to identify
agents that may be effective only in some patient subpopulations.
Summary
Although there has been remarkable progress in our understanding of the immunology and phenotype of lupus nephritis current therapies have insufficient efficacy. As new therapies emerge, improved clinical design coupled with mechanistic studies will be needed to identify agents that may be effective only in some patient subpopulations.
Lippincott Williams & Wilkins